 |
|
|
| |
HIGH RATES OF VIROLOGIC SUPPRESSION WITH DTG/3TC IN NEWLY DIAGNOSED
ADULTS WITH HIV-1 INFECTION AND BASELINE VIRAL LOAD ≥500,000
C/ML: 48-WEEK SUBGROUP ANALYSIS OF THE STAT STUDY
|
| |
| |
IDWeek 2021 Sept 29-Oct 3
Charlotte-Paige Rolle,1 Mezgebe Berhe,2 Tulika Singh,3 Roberto Ortiz,4 Anson Wurapa,5 Moti Ramgopal,6 Dushyantha T. Jayaweera,7 Peter A. Leone,8 Jessica E. Matthews,8 Michael Cupo,9 Mark R. Underwood,8 Konstantinos Angelis,10 Brian R. Wynne,8 Deanna Merrill,8 Christopher Nguyen,8 Jean van Wyk,11 Andrew R. Zolopa8,12
1Orlando Immunology Center, Orlando, FL, USA; 2Baylor University Medical Center, Dallas, TX, USA; 3Desert AIDS Project, Palm Springs, CA, USA;
4Bliss Healthcare Services, Orlando, FL, USA; 5Infectious Disease Specialists of Atlanta, Decatur, GA, USA; 6Midway Immunology and Research Center, Fort Pierce, FL, USA; 7University of Miami Miller School of Medicine, Miami, FL, USA; 8ViiV Healthcare, Research Triangle Park, NC, USA; 9GlaxoSmithKline, Upper Providence, PA, USA; 10GlaxoSmithKline, Brentford, UK; 11ViiV Healthcare, Brentford, UK; 12Stanford University, Palo Alto, CA, USA
|
| |
|
|
|
|
|
